APO Research

APO RESEARCH · REPORT

Vitamins and Supplements for Joint Health

Selected research

Market Outlook & Growth Opportunities

Global Vitamins and Supplements for Joint Health Market Outlook and Growth Opportunities 2026

Market perspective

The global Vitamins and Supplements for Joint Health market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Vitamins and Supplements for Joint Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Vitamins and Supplements for Joint Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vitamins and Supplements for Joint Health is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Vitamins and Supplements for Joint Health market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Vitamins and Supplements for Joint Health market include A&Z Pharmaceutical, Amway (Nutrilite), Bio Island, BioTrust Nutrition, Blackmores, Bluebonnet Nutrition, By-Health, GNC Holdings and GSK-Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Vitamins and Supplements for Joint Health market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vitamins and Supplements for Joint Health and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vitamins and Supplements for Joint Health revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Vitamins and Supplements for Joint Health market.

Vitamins and Supplements for Joint Health Segment by Company

A&Z Pharmaceutical

Amway (Nutrilite)

Bio Island

BioTrust Nutrition

Blackmores

Bluebonnet Nutrition

By-Health

GNC Holdings

GSK-Pfizer

Harbin Pharmaceutical Group

High Change

Nature Made

Nature's Bounty

NOW Foods

Pure Encapsulations

Schiff

Solgar

Bayer

Shanxi Zhendong Pharmaceutical

Vitamins and Supplements for Joint Health Segment by Type

Vitamins

Health Supplements

Vitamins and Supplements for Joint Health Segment by Application

Above 60 Years Old

50-60 Years Old

19-49 Years Old

Below 12 Years Old

12-18 Years Old

Vitamins and Supplements for Joint Health Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Vitamins and Supplements for Joint Health status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Vitamins and Supplements for Joint Health key companies, revenue, market share, and recent developments.

3. To split the Vitamins and Supplements for Joint Health breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Vitamins and Supplements for Joint Health market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Vitamins and Supplements for Joint Health significant trends, drivers, influence factors in global and regions.

6. To analyze Vitamins and Supplements for Joint Health competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vitamins and Supplements for Joint Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vitamins and Supplements for Joint Health and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vitamins and Supplements for Joint Health.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vitamins and Supplements for Joint Health industry.

Chapter 3: Detailed analysis of Vitamins and Supplements for Joint Health company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Vitamins and Supplements for Joint Health in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Vitamins and Supplements for Joint Health in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Vitamins and Supplements for Joint Health Industry Trends Table 2. Vitamins and Supplements for Joint Health Industry Drivers Table 3. Vitamins and Supplements for Joint Health Industry Opportunities and Challenges Table 4. Vitamins and Supplements for Joint Health Industry Restraints Table 5. Global Vitamins and Supplements for Joint Health Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Vitamins and Supplements for Joint Health Revenue Share by Company (2021-2026) Table 7. Global Vitamins and Supplements for Joint Health Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Vitamins and Supplements for Joint Health Key Company Manufacturing Base & Headquarters Table 9. Global Vitamins and Supplements for Joint Health Company, Product Type & Application Table 10. Global Vitamins and Supplements for Joint Health Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Vitamins and Supplements for Joint Health by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Vitamins Table 15. Significant Companies of Health Supplements Table 16. Global Vitamins and Supplements for Joint Health Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Vitamins and Supplements for Joint Health Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Vitamins and Supplements for Joint Health Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Vitamins and Supplements for Joint Health Sales Value Share by Type (2021-2026) Table 20. Global Vitamins and Supplements for Joint Health Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Above 60 Years Old Table 22. Significant Companies of 50-60 Years Old Table 23. Significant Companies of 19-49 Years Old Table 24. Significant Companies of Below 12 Years Old Table 25. Significant Companies of 12-18 Years Old Table 26. Global Vitamins and Supplements for Joint Health Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Vitamins and Supplements for Joint Health Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Vitamins and Supplements for Joint Health Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Vitamins and Supplements for Joint Health Sales Value Share by Application (2021-2026) Table 30. Global Vitamins and Supplements for Joint Health Sales Value Share by Application (2027-2032) Table 31. Global Vitamins and Supplements for Joint Health Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Vitamins and Supplements for Joint Health Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Vitamins and Supplements for Joint Health Sales Value Share by Region (2021-2026) Table 34. Global Vitamins and Supplements for Joint Health Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Vitamins and Supplements for Joint Health Sales Value Share by Region (2027-2032) Table 36. Global Vitamins and Supplements for Joint Health Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Vitamins and Supplements for Joint Health Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Vitamins and Supplements for Joint Health Sales Value Market Share by Country (2021-2026) Table 39. Global Vitamins and Supplements for Joint Health Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Vitamins and Supplements for Joint Health Sales Value Market Share by Country (2027-2032) Table 41. A&Z Pharmaceutical Company Information Table 42. A&Z Pharmaceutical Business Overview Table 43. A&Z Pharmaceutical Vitamins and Supplements for Joint Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. A&Z Pharmaceutical Vitamins and Supplements for Joint Health Product Portfolio Table 45. A&Z Pharmaceutical Recent Development Table 46. Amway (Nutrilite) Company Information Table 47. Amway (Nutrilite) Business Overview Table 48. Amway (Nutrilite) Vitamins and Supplements for Joint Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Amway (Nutrilite) Vitamins and Supplements for Joint Health Product Portfolio Table 50. Amway (Nutrilite) Recent Development Table 51. Bio Island Company Information Table 52. Bio Island Business Overview Table 53. Bio Island Vitamins and Supplements for Joint Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Bio Island Vitamins and Supplements for Joint Health Product Portfolio Table 55. Bio Island Recent Development Table 56. BioTrust Nutrition Company Information Table 57. BioTrust Nutrition Business Overview Table 58. BioTrust Nutrition Vitamins and Supplements for Joint Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. BioTrust Nutrition Vitamins and Supplements for Joint Health Product Portfolio Table 60. BioTrust Nutrition Recent Development Table 61. Blackmores Company Information Table 62. Blackmores Business Overview Table 63. Blackmores Vitamins and Supplements for Joint Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Blackmores Vitamins and Supplements for Joint Health Product Portfolio Table 65. Blackmores Recent Development Table 66. Bluebonnet Nutrition Company Information Table 67. Bluebonnet Nutrition Business Overview Table 68. Bluebonnet Nutrition Vitamins and Supplements for Joint Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Bluebonnet Nutrition Vitamins and Supplements for Joint Health Product Portfolio Table 70. Bluebonnet Nutrition Recent Development Table 71. By-Health Company Information Table 72. By-Health Business Overview Table 73. By-Health Vitamins and Supplements for Joint Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. By-Health Vitamins and Supplements for Joint Health Product Portfolio Table 75. By-Health Recent Development Table 76. GNC Holdings Company Information Table 77. GNC Holdings Business Overview Table 78. GNC Holdings Vitamins and Supplements for Joint Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. GNC Holdings Vitamins and Supplements for Joint Health Product Portfolio Table 80. GNC Holdings Recent Development Table 81. GSK-Pfizer Company Information Table 82. GSK-Pfizer Business Overview Table 83. GSK-Pfizer Vitamins and Supplements for Joint Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. GSK-Pfizer Vitamins and Supplements for Joint Health Product Portfolio Table 85. GSK-Pfizer Recent Development Table 86. Harbin Pharmaceutical Group Company Information Table 87. Harbin Pharmaceutical Group Business Overview Table 88. Harbin Pharmaceutical Group Vitamins and Supplements for Joint Health Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Harbin Pharmaceutical Group Vitamins and Supplements for Joint Health Product Portfolio Table 90. Harbin Pharmaceutical Group Recent Development Table 91. High Change Company Information Table 92. High Change Business Overview Table 93. High Change Vitamins and Supplements for Joint Health Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. High Change Vitamins and Supplements for Joint Health Product Portfolio Table 95. High Change Recent Development Table 96. Nature Made Company Information Table 97. Nature Made Business Overview Table 98. Nature Made Vitamins and Supplements for Joint Health Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Nature Made Vitamins and Supplements for Joint Health Product Portfolio Table 100. Nature Made Recent Development Table 101. Nature's Bounty Company Information Table 102. Nature's Bounty Business Overview Table 103. Nature's Bounty Vitamins and Supplements for Joint Health Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Nature's Bounty Vitamins and Supplements for Joint Health Product Portfolio Table 105. Nature's Bounty Recent Development Table 106. NOW Foods Company Information Table 107. NOW Foods Business Overview Table 108. NOW Foods Vitamins and Supplements for Joint Health Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. NOW Foods Vitamins and Supplements for Joint Health Product Portfolio Table 110. NOW Foods Recent Development Table 111. Pure Encapsulations Company Information Table 112. Pure Encapsulations Business Overview Table 113. Pure Encapsulations Vitamins and Supplements for Joint Health Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Pure Encapsulations Vitamins and Supplements for Joint Health Product Portfolio Table 115. Pure Encapsulations Recent Development Table 116. Schiff Company Information Table 117. Schiff Business Overview Table 118. Schiff Vitamins and Supplements for Joint Health Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Schiff Vitamins and Supplements for Joint Health Product Portfolio Table 120. Schiff Recent Development Table 121. Solgar Company Information Table 122. Solgar Business Overview Table 123. Solgar Vitamins and Supplements for Joint Health Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Solgar Vitamins and Supplements for Joint Health Product Portfolio Table 125. Solgar Recent Development Table 126. Bayer Company Information Table 127. Bayer Business Overview Table 128. Bayer Vitamins and Supplements for Joint Health Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Bayer Vitamins and Supplements for Joint Health Product Portfolio Table 130. Bayer Recent Development Table 131. Shanxi Zhendong Pharmaceutical Company Information Table 132. Shanxi Zhendong Pharmaceutical Business Overview Table 133. Shanxi Zhendong Pharmaceutical Vitamins and Supplements for Joint Health Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Shanxi Zhendong Pharmaceutical Vitamins and Supplements for Joint Health Product Portfolio Table 135. Shanxi Zhendong Pharmaceutical Recent Development Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. Vitamins and Supplements for Joint Health Product Image Figure 2. Global Vitamins and Supplements for Joint Health Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vitamins and Supplements for Joint Health Market Size (2021-2032) & (US$ Million) Figure 4. Global Vitamins and Supplements for Joint Health Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Vitamins Image Figure 8. Health Supplements Image Figure 9. Global Vitamins and Supplements for Joint Health Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Vitamins and Supplements for Joint Health Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Vitamins and Supplements for Joint Health Sales Value Share by Type (2021-2032) Figure 12. Above 60 Years Old Image Figure 13. 50-60 Years Old Image Figure 14. 19-49 Years Old Image Figure 15. Below 12 Years Old Image Figure 16. 12-18 Years Old Image Figure 17. Global Vitamins and Supplements for Joint Health Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Vitamins and Supplements for Joint Health Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Vitamins and Supplements for Joint Health Sales Value Share by Application (2021-2032) Figure 20. Global Vitamins and Supplements for Joint Health Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Vitamins and Supplements for Joint Health Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Vitamins and Supplements for Joint Health Sales Value (2021-2032) & (US$ Million) Figure 23. North America Vitamins and Supplements for Joint Health Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Vitamins and Supplements for Joint Health Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Vitamins and Supplements for Joint Health Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Vitamins and Supplements for Joint Health Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Vitamins and Supplements for Joint Health Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Vitamins and Supplements for Joint Health Sales Value (2021-2032) & (US$ Million) Figure 29. South America Vitamins and Supplements for Joint Health Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Vitamins and Supplements for Joint Health Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Vitamins and Supplements for Joint Health Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Vitamins
  • Health Supplements
Applications
  • Above 60 Years Old
  • 50-60 Years Old
  • 19-49 Years Old
  • Below 12 Years Old
  • 12-18 Years Old
Companies covered
  • A&Z Pharmaceutical
  • Amway (Nutrilite)
  • Bio Island
  • BioTrust Nutrition
  • Blackmores
  • Bluebonnet Nutrition
  • By-Health
  • GNC Holdings
  • GSK-Pfizer
  • Harbin Pharmaceutical Group
  • High Change
  • Nature Made
  • Nature's Bounty
  • NOW Foods
  • Pure Encapsulations
  • Schiff
  • Solgar
  • Bayer
  • Shanxi Zhendong Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Vitamins and Supplements for Joint Health Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Vitamins and Supplements for Joint Health Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Vitamins and Supplements for Joint Health Market Dynamics
  1. 2.1 Vitamins and Supplements for Joint Health Industry Trends
  2. 2.2 Vitamins and Supplements for Joint Health Industry Drivers
  3. 2.3 Vitamins and Supplements for Joint Health Industry Opportunities and Challenges
  4. 2.4 Vitamins and Supplements for Joint Health Industry Restraints
3 Vitamins and Supplements for Joint Health Market by Company
  1. 3.1 Global Vitamins and Supplements for Joint Health Company Revenue Ranking in 2025
  2. 3.2 Global Vitamins and Supplements for Joint Health Revenue by Company (2021-2026)
  3. 3.3 Global Vitamins and Supplements for Joint Health Company Ranking (2024-2026)
  4. 3.4 Global Vitamins and Supplements for Joint Health Company Manufacturing Base and Headquarters
  5. 3.5 Global Vitamins and Supplements for Joint Health Company Product Type and Application
  6. 3.6 Global Vitamins and Supplements for Joint Health Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Vitamins and Supplements for Joint Health Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Vitamins and Supplements for Joint Health Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Vitamins and Supplements for Joint Health Market by Type
  1. 4.1 Vitamins and Supplements for Joint Health Type Introduction
  2. 4.1.1 Vitamins
  3. 4.1.2 Health Supplements
  4. 4.2 Global Vitamins and Supplements for Joint Health Sales Value by Type
  5. 4.2.1 Global Vitamins and Supplements for Joint Health Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Vitamins and Supplements for Joint Health Sales Value by Type (2021-2032)
  7. 4.2.3 Global Vitamins and Supplements for Joint Health Sales Value Share by Type (2021-2032)
5 Vitamins and Supplements for Joint Health Market by Application
  1. 5.1 Vitamins and Supplements for Joint Health Application Introduction
  2. 5.1.1 Above 60 Years Old
  3. 5.1.2 50-60 Years Old
  4. 5.1.3 19-49 Years Old
  5. 5.1.4 Below 12 Years Old
  6. 5.1.5 12-18 Years Old
  7. 5.2 Global Vitamins and Supplements for Joint Health Sales Value by Application
  8. 5.2.1 Global Vitamins and Supplements for Joint Health Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Vitamins and Supplements for Joint Health Sales Value by Application (2021-2032)
  10. 5.2.3 Global Vitamins and Supplements for Joint Health Sales Value Share by Application (2021-2032)
6 Vitamins and Supplements for Joint Health Regional Value Analysis
  1. 6.1 Global Vitamins and Supplements for Joint Health Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vitamins and Supplements for Joint Health Sales Value by Region (2021-2032)
  3. 6.2.1 Global Vitamins and Supplements for Joint Health Sales Value by Region: 2021-2026
  4. 6.2.2 Global Vitamins and Supplements for Joint Health Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Vitamins and Supplements for Joint Health Sales Value (2021-2032)
  7. 6.3.2 North America Vitamins and Supplements for Joint Health Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Vitamins and Supplements for Joint Health Sales Value (2021-2032)
  10. 6.4.2 Europe Vitamins and Supplements for Joint Health Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Vitamins and Supplements for Joint Health Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Vitamins and Supplements for Joint Health Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Vitamins and Supplements for Joint Health Sales Value (2021-2032)
  16. 6.6.2 South America Vitamins and Supplements for Joint Health Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Vitamins and Supplements for Joint Health Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Vitamins and Supplements for Joint Health Sales Value Share by Country, 2025 VS 2032
7 Vitamins and Supplements for Joint Health Country-level Value Analysis
  1. 7.1 Global Vitamins and Supplements for Joint Health Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Vitamins and Supplements for Joint Health Sales Value by Country (2021-2032)
  3. 7.2.1 Global Vitamins and Supplements for Joint Health Sales Value by Country (2021-2026)
  4. 7.2.2 Global Vitamins and Supplements for Joint Health Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Vitamins and Supplements for Joint Health Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Vitamins and Supplements for Joint Health Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Vitamins and Supplements for Joint Health Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 A&Z Pharmaceutical
  2. 8.1.1 A&Z Pharmaceutical Company Information
  3. 8.1.2 A&Z Pharmaceutical Business Overview
  4. 8.1.3 A&Z Pharmaceutical Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
  5. 8.1.4 A&Z Pharmaceutical Vitamins and Supplements for Joint Health Product Portfolio
  6. 8.1.5 A&Z Pharmaceutical Recent Developments
  7. 8.2 Amway (Nutrilite)
  8. 8.2.1 Amway (Nutrilite) Company Information
  9. 8.2.2 Amway (Nutrilite) Business Overview
  10. 8.2.3 Amway (Nutrilite) Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Amway (Nutrilite) Vitamins and Supplements for Joint Health Product Portfolio
  12. 8.2.5 Amway (Nutrilite) Recent Developments
  13. 8.3 Bio Island
  14. 8.3.1 Bio Island Company Information
  15. 8.3.2 Bio Island Business Overview
  16. 8.3.3 Bio Island Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bio Island Vitamins and Supplements for Joint Health Product Portfolio
  18. 8.3.5 Bio Island Recent Developments
  19. 8.4 BioTrust Nutrition
  20. 8.4.1 BioTrust Nutrition Company Information
  21. 8.4.2 BioTrust Nutrition Business Overview
  22. 8.4.3 BioTrust Nutrition Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BioTrust Nutrition Vitamins and Supplements for Joint Health Product Portfolio
  24. 8.4.5 BioTrust Nutrition Recent Developments
  25. 8.5 Blackmores
  26. 8.5.1 Blackmores Company Information
  27. 8.5.2 Blackmores Business Overview
  28. 8.5.3 Blackmores Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Blackmores Vitamins and Supplements for Joint Health Product Portfolio
  30. 8.5.5 Blackmores Recent Developments
  31. 8.6 Bluebonnet Nutrition
  32. 8.6.1 Bluebonnet Nutrition Company Information
  33. 8.6.2 Bluebonnet Nutrition Business Overview
  34. 8.6.3 Bluebonnet Nutrition Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bluebonnet Nutrition Vitamins and Supplements for Joint Health Product Portfolio
  36. 8.6.5 Bluebonnet Nutrition Recent Developments
  37. 8.7 By-Health
  38. 8.7.1 By-Health Company Information
  39. 8.7.2 By-Health Business Overview
  40. 8.7.3 By-Health Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
  41. 8.7.4 By-Health Vitamins and Supplements for Joint Health Product Portfolio
  42. 8.7.5 By-Health Recent Developments
  43. 8.8 GNC Holdings
  44. 8.8.1 GNC Holdings Company Information
  45. 8.8.2 GNC Holdings Business Overview
  46. 8.8.3 GNC Holdings Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GNC Holdings Vitamins and Supplements for Joint Health Product Portfolio
  48. 8.8.5 GNC Holdings Recent Developments
  49. 8.9 GSK-Pfizer
  50. 8.9.1 GSK-Pfizer Company Information
  51. 8.9.2 GSK-Pfizer Business Overview
  52. 8.9.3 GSK-Pfizer Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
  53. 8.9.4 GSK-Pfizer Vitamins and Supplements for Joint Health Product Portfolio
  54. 8.9.5 GSK-Pfizer Recent Developments
  55. 8.10 Harbin Pharmaceutical Group
  56. 8.10.1 Harbin Pharmaceutical Group Company Information
  57. 8.10.2 Harbin Pharmaceutical Group Business Overview
  58. 8.10.3 Harbin Pharmaceutical Group Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Harbin Pharmaceutical Group Vitamins and Supplements for Joint Health Product Portfolio
  60. 8.10.5 Harbin Pharmaceutical Group Recent Developments
  61. 8.11 High Change
  62. 8.11.1 High Change Company Information
  63. 8.11.2 High Change Business Overview
  64. 8.11.3 High Change Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
  65. 8.11.4 High Change Vitamins and Supplements for Joint Health Product Portfolio
  66. 8.11.5 High Change Recent Developments
  67. 8.12 Nature Made
  68. 8.12.1 Nature Made Company Information
  69. 8.12.2 Nature Made Business Overview
  70. 8.12.3 Nature Made Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Nature Made Vitamins and Supplements for Joint Health Product Portfolio
  72. 8.12.5 Nature Made Recent Developments
  73. 8.13 Nature's Bounty
  74. 8.13.1 Nature's Bounty Company Information
  75. 8.13.2 Nature's Bounty Business Overview
  76. 8.13.3 Nature's Bounty Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Nature's Bounty Vitamins and Supplements for Joint Health Product Portfolio
  78. 8.13.5 Nature's Bounty Recent Developments
  79. 8.14 NOW Foods
  80. 8.14.1 NOW Foods Company Information
  81. 8.14.2 NOW Foods Business Overview
  82. 8.14.3 NOW Foods Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
  83. 8.14.4 NOW Foods Vitamins and Supplements for Joint Health Product Portfolio
  84. 8.14.5 NOW Foods Recent Developments
  85. 8.15 Pure Encapsulations
  86. 8.15.1 Pure Encapsulations Company Information
  87. 8.15.2 Pure Encapsulations Business Overview
  88. 8.15.3 Pure Encapsulations Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Pure Encapsulations Vitamins and Supplements for Joint Health Product Portfolio
  90. 8.15.5 Pure Encapsulations Recent Developments
  91. 8.16 Schiff
  92. 8.16.1 Schiff Company Information
  93. 8.16.2 Schiff Business Overview
  94. 8.16.3 Schiff Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Schiff Vitamins and Supplements for Joint Health Product Portfolio
  96. 8.16.5 Schiff Recent Developments
  97. 8.17 Solgar
  98. 8.17.1 Solgar Company Information
  99. 8.17.2 Solgar Business Overview
  100. 8.17.3 Solgar Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Solgar Vitamins and Supplements for Joint Health Product Portfolio
  102. 8.17.5 Solgar Recent Developments
  103. 8.18 Bayer
  104. 8.18.1 Bayer Company Information
  105. 8.18.2 Bayer Business Overview
  106. 8.18.3 Bayer Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Bayer Vitamins and Supplements for Joint Health Product Portfolio
  108. 8.18.5 Bayer Recent Developments
  109. 8.19 Shanxi Zhendong Pharmaceutical
  110. 8.19.1 Shanxi Zhendong Pharmaceutical Company Information
  111. 8.19.2 Shanxi Zhendong Pharmaceutical Business Overview
  112. 8.19.3 Shanxi Zhendong Pharmaceutical Vitamins and Supplements for Joint Health Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Shanxi Zhendong Pharmaceutical Vitamins and Supplements for Joint Health Product Portfolio
  114. 8.19.5 Shanxi Zhendong Pharmaceutical Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research